In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
暂无分享,去创建一个
M. Mohty | M. Samur | H. Avet-Loiseau | M. Macro | X. Leleu | J. Corre | D. Bouscary | A. Cleynen | N. Munshi | A. Perrot | F. Orsini-Piocelle | S. Bréchignac | S. Manier | M. Chrétien | F. Lifermann | T. Cazaubiel | L. Gastaud | C. Mazzotti | R. Lannes | Didier Adiko | M. Divoux | A. Schavgoulidze
[1] R. Fonseca,et al. Chromosome 1q21 abnormalities in multiple myeloma , 2021, Blood Cancer Journal.
[2] G. Morgan,et al. Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial , 2020, Leukemia.
[3] M. Mohty,et al. Del17p without TP53 mutation confers poor prognosis in intensively treated newly diagnosed multiple myeloma patients. , 2020, Blood.
[4] G. Parmigiani,et al. Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Mohty,et al. Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk , 2019, Haematologica.
[6] Johannes L. Schönberger,et al. SciPy 1.0: fundamental algorithms for scientific computing in Python , 2019, Nature Methods.
[7] D. Dingli,et al. Impact of acquired del(17p) in multiple myeloma. , 2019, Blood advances.
[8] O. Decaux,et al. Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] H. Goldschmidt,et al. High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma. , 2019, Blood.
[10] Pingping Qu,et al. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis , 2018, Leukemia.
[11] Joshua F. McMichael,et al. Visualizing tumor evolution with the fishplot package for R , 2016, bioRxiv.
[12] B. Pégourié,et al. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients , 2014, Leukemia.
[13] G. Parmigiani,et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma , 2014, Nature Communications.
[14] A. McKenna,et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. , 2014, Cancer cell.
[15] J. Carpten,et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. , 2012, Blood.
[16] G. Morgan,et al. The genetic architecture of multiple myeloma , 2012, Nature Reviews Cancer.
[17] Trevor J Pugh,et al. Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.
[18] John D. Hunter,et al. Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.
[19] F. Magrangeas,et al. Genetic heterogeneity in multiple myeloma , 2005, Leukemia.
[20] O. Cope,et al. Multiple myeloma. , 1948, The New England journal of medicine.